Part of the Public Health Commons

Works by Mariko Kita in Public Health

2020

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Karl E. Peace

2018

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace

2015

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Biostatistics Faculty Publications

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Biostatistics Faculty Presentations

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace